Huipeng Xu

Huipeng Xu

Auto-generated profile, based on publicly available information

Huipeng Xu

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
SHSiyu He
Siyu He
LWLi Wu
Li Wu
XLXue Li
Xue Li
HSHongyu Sun
Hongyu Sun
TXTing Xiong
Ting Xiong
JZJiwen Zhang
Jiwen Zhang
Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular for drug delivery. There is a growing interest over the last decades in the design of engineered MOFs with controlled sizes for a variety of biomedical applications. This article presents an overall review and perspectives of MOFs-based drug delivery systems (DDSs), starting with the MOFs classification adapted for DDSs based on the types of constituting metals and ligands. Then, the synthesis and characterization of MOFs for DDSs are developed, followed by the drug loading strategies, applications, biopharmaceutics and quality control. Importantly, a variety of representative applications of MOFs are detailed from a point of view of applications in pharmaceutics, diseases therapy and advanced DDSs. In particular, the biopharmaceutics and quality control of MOFs-based DDSs are summarized with critical issues to be addressed. Finally, challenges in MOFs development for DDSs are discussed, such as biostability, biosafety, biopharmaceutics and nomenclature.

13 June 2023 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
JSJiawen Su
Jiawen Su
YLYan Liu
Yan Liu
HSHongyu Sun
Hongyu Sun
ANAbid Naeem
Abid Naeem
HXHuipeng Xu
Huipeng Xu
LWLi Wu
Li Wu
Nasal drug delivery efficiency is highly dependent on the position in which the drug is deposited in the nasal cavity. However, no reliable method is currently available to assess its impact on delivery performance. In this study, a biomimetic nasal model based on three-dimensional (3D) reconstruction and three-dimensional printing (3DP) technology was developed for visualizing the deposition of drug powders in the nasal cavity. The results showed significant differences in cavity area and volume and powder distribution in the anterior part of the biomimetic nasal model of Chinese males and females. The nasal cavity model was modified with dimethicone and validated to be suitable for the deposition test. The experimental device produced the most satisfactory results with five spray times. Furthermore, particle sizes and spray angles were found to significantly affect the experimental device's performance and alter drug distribution, respectively. Additionally, mometasone furoate (MF) nasal spray (NS) distribution patterns were investigated in a goat nasal cavity model and three male goat noses, confirming the in vitro and in vivo correlation. In conclusion, the developed human nasal structure biomimetic device has the potential to be a valuable tool for assessing nasal drug delivery system deposition and distribution.

2 March 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
QNQin Nie
Qin Nie
CWCaifen Wang
Caifen Wang
HXHuipeng Xu
Huipeng Xu
PMPriyanka Mittal
Priyanka Mittal
ANAbid Naeem
Abid Naeem
JZJiwen Zhang
Jiwen Zhang